Free Trial

Azenta (NASDAQ:AZTA) Hits New 1-Year Low - What's Next?

Azenta logo with Medical background
Remove Ads

Shares of Azenta, Inc. (NASDAQ:AZTA - Get Free Report) hit a new 52-week low on Thursday . The company traded as low as $35.06 and last traded at $35.47, with a volume of 95862 shares. The stock had previously closed at $36.41.

Analysts Set New Price Targets

AZTA has been the topic of several research analyst reports. Stephens restated an "overweight" rating and set a $60.00 target price on shares of Azenta in a research report on Thursday, January 2nd. Evercore ISI lifted their price target on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research report on Thursday, February 6th. TD Cowen upgraded Azenta to a "hold" rating in a report on Thursday, February 27th. Finally, Needham & Company LLC lifted their price objective on Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a report on Thursday, February 6th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $58.75.

View Our Latest Report on Azenta

Azenta Stock Performance

The business has a fifty day simple moving average of $45.11 and a 200 day simple moving average of $46.27. The stock has a market cap of $1.58 billion, a price-to-earnings ratio of -11.62 and a beta of 1.52.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, equities research analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Remove Ads

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Picton Mahoney Asset Management grew its position in shares of Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after purchasing an additional 532 shares during the period. Headlands Technologies LLC acquired a new stake in Azenta in the 4th quarter worth about $40,000. Covestor Ltd grew its holdings in Azenta by 64.2% in the 4th quarter. Covestor Ltd now owns 2,043 shares of the company's stock valued at $102,000 after buying an additional 799 shares during the period. KBC Group NV increased its stake in shares of Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after acquiring an additional 698 shares during the last quarter. Finally, Quarry LP purchased a new position in shares of Azenta during the 4th quarter worth about $110,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Azenta Company Profile

(Get Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Further Reading

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads